APA-01

PharmAla Biotech Holdings Inc. (OTC:MDXXF), a Canadian company specializing in MDMA research and development, announced its selection as a supplier for a clinical trial at the University of Texas, San Antonio. The trial will focus on testing a novel dosage form of PharmAla's proprietary LaNeo MDMA...